TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods.

Wael Saber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.